Modular Medical (NASDAQ: MODD) has announced the completion of an extensive market research study conducted with cardiometabolic patient insights company closely held Thrivable to evaluate perceptions of Modular...
Modular Medical (NASDAQ: MODD) has announced that the Institutional Review Board (IRB) has granted approval to conduct an in-house study of its next-generation Pivot insulin delivery system using insulin on people with...
Modular Medicine (NASDAQ: MODD) has announced its participation at the Association of Diabetes Care & Education Specialists (ADCES) Conference, August 8 to 11, 2025, where it will debut a coming soon campaign for...